NS Healthcare is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
Home » pressreleases » Haselmeier Group announces the extension and reorganization of its executive board

a leading developer and manufacturer of innovative self-injection devices

Press
Release

Haselmeier Group announces the extension and reorganization of its executive board

The Haselmeier Group has decided to reinforce and reorganise its executive board. Mr Gert Weber has been nominated by the board of directors of Medico Invest AG as chief executive officer (CEO) of the Haselmeier Group.

This nomination is effective starting 1 July 2015. Mr Weber brings more than 20 years of experience in the manufacturing and technological industries and has filled various executive management positions, the last being managing director and vice-president responsible for operations and information technology (IT) at Avnet TS (formerly Magirus Group).

With his experience and expertise, Mr. Weber shall contribute to strengthen Haselmeier’s position and performance in the medical device industry and beyond.

Mr Weber joined Haselmeier as chief information officer (CIO) on 1 May 2015, and will continue to lead Haselmeier’s efforts to build up efficient organization and state-of-the-art IT. Haselmeier is committed to position IT as a strategic growth driver for its operations as well as an opportunity to develop new business areas.

Mr Andreas Schieber leaves Haselmeier, starting 30 June 2015. Mr Schieber has – as interim chairman of the executive board – actively contributed to the structuring and installation of Haselmeier’s Group Management.

Furthermore, Haselmeier offers more clarity to its quality organisation and establishes two subgroups covering respectively quality management and quality assurance, with dedicated teams and leadership. Both groups will report into Mr Matthias Meissner who has endorsed the function of chief quality officer (CQO), effective since 1 July 2015 and on an interim basis. Mr Meissner replaces Mr Markus Dorsch who contributed to build Haselmeier’s quality management over the past ten years. Mr Meissner has been instrumental in the development of Haselmeier’s infrastructure and the installation of efficient manufacturing capabilities, and will support the installation of a global quality management.

Mr Siegfried Eichinger has been appointed chief financial officer (CFO), effective since 1 July 2015. In his extended CFO role, Mr Eichinger will lead Haselmeier’s global finance and controlling, and will be responsible for the group’s human resources management. Mr Eichinger brings more than 20 years of experience in the technological and healthcare industries and will ensure Haselmeier has sound and coordinated planning, development and management of its resources on a group-wide basis.

With the reinforcement of its executive board, Haselmeier demonstrates its commitment to sustainable development towards high performance, breakthrough innovations and excellent service for its customers.

Contact a leading developer and manufacturer of innovative self-injection devices

a leading developer and manufacturer of innovative self-injection devices